Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
76.97 USD | +1.60% | +11.78% | +313.59% |
05-03 | Wall St set to open sharply higher on soft jobs data | RE |
05-03 | Amgen shares jump after teasing weight-loss drug data, rivals slip | RE |
Business Summary
Number of employees: 28
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brian Lian
FOU | Founder | 58 | 23/09/12 |
Gregory Zante
DFI | Director of Finance/CFO | 53 | 04/01/16 |
Marianne Mancini
COO | Chief Operating Officer | 59 | 30/04/15 |
Michael Morneau
ADM | Chief Administrative Officer | 58 | 30/04/14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Foehr
BRD | Director/Board Member | 51 | 30/04/14 |
J. Singleton
BRD | Director/Board Member | 71 | 30/04/14 |
Charles Rowland
BRD | Director/Board Member | 65 | 30/06/17 |
Lawson Macartney
CHM | Chairman | 66 | 30/04/14 |
Brian Lian
FOU | Founder | 58 | 23/09/12 |
S. Rouan
BRD | Director/Board Member | 61 | 30/06/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 110,268,210 | 103,616,038 ( 93.97 %) | 0 | 93.97 % |
Company contact information
Viking Therapeutics, Inc.
9920 Pacific Heights Boulevard Suite 350
92121, San Diego
+858 704 4660
http://www.vikingtherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+313.59% | 8.35B | |
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B |
- Stock Market
- Equities
- VKTX Stock
- Company Viking Therapeutics, Inc.